Tirzepatide (Mounjaro) has rapidly become one of the most discussed medications in diabetes and obesity medicine. Its dual GIP/GLP-1 receptor agonist mechanism produces unprecedented reductions in blood sugar and body weight. But what does the evidence say about its cardiovascular effects — and how does it compare to semaglutide? How Tirzepatide Works Unlike semaglutide, which…
A large study published this month in Nature Medicine helps answer a question many patients and clinicians have been asking: Do the newer diabetes medications, semaglutide and tirzepatide, actually protect the heart? The study demonstrates that both medications provide cardiovascular protection through solid real-world evidence. [1] In this large real-world observational study, researchers from Mass…
This blog article will explore the new diabetes medication called Mounjaro, also known as Tirzepatide. Mounjaro is a new prescription medication used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes. It is also approved for weight loss in adults with overweight or obesity who have type 2…
Urdu 
English